Literature DB >> 20682138

Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States.

Kathryn M Curtis1, Denise J Jamieson, Herbert B Peterson, Polly A Marchbanks.   

Abstract

BACKGROUND: The Centers for Disease Control and Prevention (CDC) recently adapted global guidance on contraceptive use from the World Health Organization (WHO) to create the United States Medical Eligibility Criteria for Contraceptive Use (MEC). This guidance includes recommendations for use of specific contraceptive methods by people with certain characteristics or medical conditions. STUDY
DESIGN: CDC determined the need and scope for the adaptation, conducted 12 systematic reviews of the scientific evidence and convened a meeting of health professionals to discuss recommendations based on the evidence.
RESULTS: The vast majority of the US guidance is the same as the WHO guidance and addresses over 160 characteristics or medical conditions. Modifications were made to WHO recommendations for six medical conditions, and recommendations were developed for six new medical conditions.
CONCLUSION: The US MEC is intended to serve as a source of clinical guidance for providers as they counsel clients about contraceptive method choices. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20682138     DOI: 10.1016/j.contraception.2010.02.014

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  10 in total

Review 1.  Keys to long-term care of the liver transplant recipient.

Authors:  Kymberly D Watt
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-13       Impact factor: 46.802

Review 2. 

Authors:  Sabrina Lorico; Blaine Colton
Journal:  Can Fam Physician       Date:  2020-06       Impact factor: 3.275

3.  Provision of contraceptive services to women with diabetes mellitus.

Authors:  Eleanor Bimla Schwarz; Debbie Postlethwaite; Yun-Yi Hung; Eric Lantzman; Mary Anne Armstrong; Michael A Horberg
Journal:  J Gen Intern Med       Date:  2011-09-16       Impact factor: 5.128

Review 4.  A systematic review of early postpartum medroxyprogesterone receipt and early breastfeeding cessation: evaluating the methodological rigor of the evidence.

Authors:  Elizabeth A Brownell; I Diana Fernandez; Cynthia R Howard; Susan G Fisher; Sharon R Ternullo; Ryan J J Buckley; Ann M Dozier
Journal:  Breastfeed Med       Date:  2011-11-15       Impact factor: 1.817

Review 5.  Putting risk into perspective: the US medical eligibility criteria for contraceptive use.

Authors:  Kathryn M Curtis; Naomi K Tepper; Polly A Marchbanks
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

6.  Contraception in patients with heart failure.

Authors:  Tara Sedlak; C Noel Bairey Merz; Chrisandra Shufelt; Kimberly D Gregory; Michele A Hamilton
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

Review 7.  Vaginal ring delivery of selective progesterone receptor modulators for contraception.

Authors:  Jeffrey T Jensen
Journal:  Contraception       Date:  2012-10-04       Impact factor: 3.375

8.  Computer-assisted provision of hormonal contraception in acute care settings.

Authors:  Eleanor B Schwarz; Elizabeth J Burch; Sara M Parisi; Kathleen P Tebb; Daniel Grossman; Ateev Mehrotra; Ralph Gonzales
Journal:  Contraception       Date:  2012-08-24       Impact factor: 3.375

9.  Counseling about medication-induced birth defects with clinical decision support in primary care.

Authors:  Eleanor Bimla Schwarz; Sara M Parisi; Steven M Handler; Gideon Koren; Grant Shevchik; Gary S Fischer
Journal:  J Womens Health (Larchmt)       Date:  2013-08-09       Impact factor: 2.681

Review 10.  Medication management and pharmacokinetic changes after bariatric surgery.

Authors:  Sabrina Lorico; Blaine Colton
Journal:  Can Fam Physician       Date:  2020-06       Impact factor: 3.275

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.